HECO U1 - Pharm Business Firm1-2

Embed Size (px)

Citation preview

  • 7/27/2019 HECO U1 - Pharm Business Firm1-2

    1/38

    THE

    PHARMACEUTICALBUSINESS

  • 7/27/2019 HECO U1 - Pharm Business Firm1-2

    2/38

    TYPES OF BUSINESS FIRMS

    2. Financial Business

    3. Information Business

    4. Manufacturers

    5. Real Estate Business

    1. Agriculture and Mining business

    6. Retailers and Distributors

    7. Service Businesses8. Transportation Business

    9. Utilities

  • 7/27/2019 HECO U1 - Pharm Business Firm1-2

    3/38

    FORMS OF BUSINESS ORGANIZATIONS

    Business Firms are organized into 3 distinct

    groups

    1. The major forms

    2. The minor forms

    3. The modified corporate form

  • 7/27/2019 HECO U1 - Pharm Business Firm1-2

    4/38

    THE MAJOR FORMS OF BUSINESSORGANIZATION

    2. Partnership

    3. Corporation

    1.Sole Proprietorship

  • 7/27/2019 HECO U1 - Pharm Business Firm1-2

    5/38

    KINDS OF PARTNERSHIP

    1. General Partner

    2. Limited Partner

    3. Universal Partner

    4. Capitalist Partner

    5. Industrial Partner

    6. Silent Partner

    7. Secret Partner

    8. Dormant Partner

    9. Nominal Partner

  • 7/27/2019 HECO U1 - Pharm Business Firm1-2

    6/38

    2 TYPES OF CORPORATION

    1. Public Corporation

    2. Private Corporation

    A. Closed Corporation

    B. Open Corporation

  • 7/27/2019 HECO U1 - Pharm Business Firm1-2

    7/38

  • 7/27/2019 HECO U1 - Pharm Business Firm1-2

    8/38

    THE MODIFIED CORPORATE FORM OFBUSINESS ORGANIZATION

    1. Cooperatives

    a. Credit union d. Consumers cooperative

    b. Producers cooperative e. Service cooperativec. Marketing cooperative

    2. Mutual companies

    a. Mutual savings banks

    b. Mutual insurance company

  • 7/27/2019 HECO U1 - Pharm Business Firm1-2

    9/38

    THE PHARMACEUTICAL HEALTH CAREINDUSTRY

  • 7/27/2019 HECO U1 - Pharm Business Firm1-2

    10/38

    THE WORLD DRUG MARKET

    Key World Markets Drug Sales in US$ Billion

    1. United states 189.81

    2. Canada 9.41

    3. United Kingdom 14.584. European Markets 82.42

    5. Japan 55.69

    6. France 20.17

    7. Germany 23.99

    8. Mexico 6.28

  • 7/27/2019 HECO U1 - Pharm Business Firm1-2

    11/38

    DISTRIBUTORS/COMPANIES DOING OWN DISTRIBUTION

    TRADERS OR SUB-DISTRIBUTORS

    DRUGSTORES 85.6% HOSPITAL 11.0% OTHER RETAIL 3.4%

    INDEPENDENT27.9%

    CHAIN57.7%

    PRIVATE8.1%

    GOVERNMENT2.9%

    INDUSTRIALCLINICS w/o

    BED3.0%

    GOVERNMENTAGENCIES

    0.4%

    CLINICS W/BEDS

    INDUSTRIALHOSP.

    C O N S U M E R

    DISTRIBUTION CHANNELS ACCORDING TO SALES

  • 7/27/2019 HECO U1 - Pharm Business Firm1-2

    12/38

    MARKET DRIVERS

    PHILIPPINE PHARMACEUTICAL MARKET

    Independent Drugstore

    Health Care Centers

    MARKET DRIVERS IN THE HOSPITAL SECTOR1. Private Hospitals

    2. PhilHealth Insurance

    Program3. Public Hospitals

    4. Clinical Pharmacy

    Practice

    5. Health MaintenanceOrganizations

    Chain Drugstores

  • 7/27/2019 HECO U1 - Pharm Business Firm1-2

    13/38

    SOURCES OF FUNDS FOR PHARMACEUTICALPRODUCTS

    Total 536 per person, 10% of National

    health expenditures

    Out-of-pocket 32%Private insurance 46%

    Medicare/PhilHealth 17%

    Other Insurance 2%

    Other Public programs 3%

  • 7/27/2019 HECO U1 - Pharm Business Firm1-2

    14/38

    PharmacyBenefit

    Manager5-15%

    Retail Pharmacy15-25%

    Brand name

    Pharmaceutical

    Companies

    70-80%

    Wholesale2-3%

    Generic Manufacturers 6%

    PATIENTS

    FLOW OF FUNDS IN THE PHARMACEUTICAL MARKET

  • 7/27/2019 HECO U1 - Pharm Business Firm1-2

    15/38

    Out-Patients

    DRUGSTORES

    Rx generated fromResidents MDs/

    Consultants

    Buys Rx

    Out-Patient Department(OPD) Hospitals

    FLOW OF RX IN THEHOSPITAL OPD

  • 7/27/2019 HECO U1 - Pharm Business Firm1-2

    16/38

    In-Patient Department(IPD) Hospitals

    In-Patient(Confined in Hospitals)

    Hospital Pharmacy

    Rx generated fromResidents MDs/

    Consultants

    Rx In Patients ChartServed by nurses

    FLOW OF RX INHOSPITAL IPD

  • 7/27/2019 HECO U1 - Pharm Business Firm1-2

    17/38

    Out-Patient In-Patient

    Emergency Rooms(ER)

    HospitalsDrugstores

    Emergency Rooms(ER)

    Hospitals

    Emergency Rooms (ER)HOSPITALS

    FLOW OF RX IN HOSPITAL ERS

    Rx bought/served

    Rx served

    Rx generated from, Residents MDs/Consultants

  • 7/27/2019 HECO U1 - Pharm Business Firm1-2

    18/38

    Channel 1 Consists of a drug

    manufacturer selling directly

    to the DOH or government

    health units and hospitalswho will in turn make the

    medicines available to the

    end-users practically for free.

    A local drug trader may serve

    as the intermediary level in

    behalf of the drug

    manufacturer in transacting

    business with DOH.

    Drug Manufacturer

    Department of HealthGovt. Health Units

    Govt. Hospitals

    End Users

    LocalDrug

    Trader

    DIFFERENT FLOWS OFPHARMACEUTICALS

  • 7/27/2019 HECO U1 - Pharm Business Firm1-2

    19/38

    Channel 2 Contains 2 middlemen level.

    A sales representative of a

    drug manufacturer selling to

    dispensing physicians who inturn sells the medicines to

    the patients (end-users)

    charging the latter

    consultation fees andmedicines given

    Drug Manufacturer

    Sales reps

    DispensingPhysicians

    END USERS

  • 7/27/2019 HECO U1 - Pharm Business Firm1-2

    20/38

    Channel 3 Contains only 1

    middlemen level,

    either an independentdistributor or retailer,

    who in turn sells the

    drug products to end-

    user

    Drug Manufacturer

    Independent

    Distributors

    END USERS

    Retailers

  • 7/27/2019 HECO U1 - Pharm Business Firm1-2

    21/38

    Channel 4 Contains 2 middlemen

    level, namely the

    wholesaler and retailer

    drugstore outlets who in

    turn sells to the end-

    users. In some

    companies, 3 middlemen

    level when its theirsalesman that facilitates

    the transactions.

    Drug Manufacturer/

    Distributors

    Wholesaler

    Retailer

    END USERS

  • 7/27/2019 HECO U1 - Pharm Business Firm1-2

    22/38

    Channel 5 Contains 3 middlemen

    level, reflecting

    jobbers who ells to thesmaller retailers

    generally are not

    served by the large

    wholesaler drugstores

    Drug Manufacturers/

    Distributions

    Wholesaler

    End Users

    JOBBERS

    Retailers

  • 7/27/2019 HECO U1 - Pharm Business Firm1-2

    23/38

    Drug Manufacturer

    IndependentDistributors

    CompanyWarehouse

    Branch operations Franchise Operations

    Mercury Drug Corp.

    Traditional Outlets Traditional Outlets

    Non-Traditional Non-TraditionalEnd Users

    FLOWCHARTDISTRIBUTION

  • 7/27/2019 HECO U1 - Pharm Business Firm1-2

    24/38

    UNILABManufacturer

    GMAWarehouse

    ProvincialWarehouse

    Drugstores Hospitals

    Industrial Clinics Non-traditional Outlets Dispensing Physicians Department of Health

    END USERS

    United LabDistribution Flow

    Chart

  • 7/27/2019 HECO U1 - Pharm Business Firm1-2

    25/38

    Drug Manufacturer

    National Distributor

    PrivateInstitution

    DispensingPhysicians

    GovernmentDistributors

    Wholesale/Retailer(drugstores)

    GovernmentAgencies

    Pure Retailers(drugstores)

    END USERS

    PharmaceuticalCompany DistributionFlow Chart

  • 7/27/2019 HECO U1 - Pharm Business Firm1-2

    26/38

    PHASES OF THE BUSINESS

    CYCLE1. The prosperity phase

    2. The crisis (or contraction or recession) phase

    3. The depression phase

    4. The recovery (or expansion) phase

  • 7/27/2019 HECO U1 - Pharm Business Firm1-2

    27/38

    CHARACTERISTICS OF PROSPERITY PHASE

    High prices and great

    business activity

    Large profits for business

    firms Production is at full

    capacity

    Increasing demand formany commodities

    Increasing demand for

    labor

    Increasing volume of sales

    Increasing volume of credit

    extensions by lenders

    Large demand for credit

    Rising interest rates

  • 7/27/2019 HECO U1 - Pharm Business Firm1-2

    28/38

    Great

    BusinessActivity

    BusinessFirms

    GreatDemand

    Raw MaterialsAnd other

    Commodities

    LABOR LANDCapital

    Resulting to

    Resulting to

    Higher outputs

    Higher sales

    Higher profits

    Higher Wages

    Higher Rent

    Higher Interest Rate

    Higher Prices ofMaterials and Supplies

    THE PROSPERITY PHASE

  • 7/27/2019 HECO U1 - Pharm Business Firm1-2

    29/38

    CRISIS OR RECESSION PHASE

    The demand for goodsdecreases

    The margin of profitsgradually shrinks

    The volume of salesdecreases

    Trading slows down

    The production of goods isreduced

    The demand for labor,

    capital, and land decreases

    Prices go down

    The ability of business firmsto meet their financial

    obligations is impaired

    Unemployment begins to

    bother labor No further extensions of

    credit or renewals of old

    loans are made by banks

  • 7/27/2019 HECO U1 - Pharm Business Firm1-2

    30/38

    Reduced

    BusinessActivity

    BusinessFirms

    ReducedDemand

    LABORRaw Materials

    And otherCommodities

    Capital LAND

    THE CRISIS OR RECESSIONPHASE

    Resulting to

    Resulting todecreasing outputs sales,

    and profits

    decreasing wages, rent,interest rates, prices ofraw materials andsupplies

  • 7/27/2019 HECO U1 - Pharm Business Firm1-2

    31/38

    DEPRESSION PHASE

    Many business haveceased operations

    Profits are minimal, if it isstill possible to make some

    Banks have plenty of idlefunds

    Banks are gradually

    reduce interest rates

    Credits starts to become

    available

    Unemployment is at its

    highest level Many unemployed persons

    are willing to work at lower

    wages

    The prices of raw materials

    and supplies are low

  • 7/27/2019 HECO U1 - Pharm Business Firm1-2

    32/38

    Greatly Reduced

    BusinessActivity

    Reduced #Of Firms

    Still Operating

    LABORRaw Materials

    And otherCommodities

    Capital LAND

    Resulting to

    Resulting to

    THE DEPRESSION PHASE

    Very LowDemand

    Minimal output,sales, and profit

    low wages, rent,interest rates

    low prices of rawmaterials and

    supplies

  • 7/27/2019 HECO U1 - Pharm Business Firm1-2

    33/38

    RECOVERY PHASE

    As the supply ofcommodities in the market

    gets exhausted, demand

    for these begin to be felt

    Optimism amongbusinessmen slowly

    develops, prodding them to

    increase business activity

    The demand for labor

    increases, resulting to a

    decrease in unemployment

    The purchasing power ofthe people rises

    The low rates of interest willattract business borrowings

    Prices slowly rise There is an increase in

    production output

    Idle plans are used and

    plans for construction ofnew ones are considered

  • 7/27/2019 HECO U1 - Pharm Business Firm1-2

    34/38

    Increasing

    BusinessActivity

    BusinessFirms

    IncreasingDemand

    LABORRaw Materials

    And otherCommodities

    Capital LAND

    Resulting to

    Resulting to

    THE RECOVERY PHASE

    increased

    outputs, sales,and profits

    increasedwages, rent,interest rates,prices of raw

    materials andsupplies

  • 7/27/2019 HECO U1 - Pharm Business Firm1-2

    35/38

    CONTROL OF BUSINESS CYCLES

    1. The stabilization of business2. Control of credit

    3. Control of public works

    4. Business forecasting

    5. Monetary readjustment

    6. Payment of high wages

    7. Economic planning

  • 7/27/2019 HECO U1 - Pharm Business Firm1-2

    36/38

    TYPES OF INFLATION

    1. Cost-push inflation is one characterized by continualdecreased in the aggregate supply, resulting to increase

    in the cost of production

    2. Demand-pull inflation is one caused by increases inaggregate demand

    3. Inertial inflationis that steady inflation that occurswhen inflation is expected to persist and the ongoing rate

    of inflation is built into contracts and peoples

    expectations

  • 7/27/2019 HECO U1 - Pharm Business Firm1-2

    37/38

    LOSERS AND GAINERS IN INFLATION

    LOSERS

    1. Fixed income earners

    2. Pensioners

    3. Creditors

    GAINERS

    1. Businessmen

    2. Speculators

    3. Debtors

    CONTROLLING INFLATION

    1. Monetary Policy

    2. Fiscal Policy

  • 7/27/2019 HECO U1 - Pharm Business Firm1-2

    38/38

    FACTORS ATTRIBUTED TO SALES DECLINE

    1. Rapid technological advances

    2. Changing consumer preferences

    for taste, flavors and colors

    3. Adherence to safety and

    efficacy

    4. Price consciousness due toinflation and deteriorating

    purchasing power